Huge opportunity for India to step up vaccine production

Updated - May 14, 2020 11:45 pm IST

Published - May 14, 2020 09:47 pm IST - HYDERABAD

The Coalition for Epidemic Preparedness Innovation (CEPI) is working towards its goal of accelerating vaccine development and ensuring equitable access, said Dr. Gagandeep Kang, Clinical Scientist and Executive Director of the Translational Health Science and Technology Institute, Faridabad.

It is playing an important role in supporting vaccine development for SARS-CoV-2 or Covid-19.

Dr. Kang, the first Indian woman scientist to be elected as a Fellow of the Royal Society and worked on vaccines for rotavirus infections and enteric diseases such as cholera and typhoid, highlighted the various types of vaccines curently being developed for SARS-CoV-2. Vaccines have a very high safety requirement as they are given to healthy people and vulnerable groups. Apart from just eliminating the disease, vaccines help in improving health and productivity.

Speaking at a webinar on ‘Vaccines for the 21st century” organised by the CovidGyan as part of its WebGyan series on Thursday, Dr.Kang stressed the need to deeply understand immune responses against new vaccines to ensure that people were protected against increased future risk.

Highlighting the example of Serum Institute of India’s meningococcal vaccine for African countries, Dr. Kang emphasised the opportunity that India has to step up vaccine production and contribute to global public health.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.